Top-level MET gene copy number gain defines a subtype of poorly differentiated pulmonary adenocarcinomas with poor prognosis-Reference-Cited by-同舟云学术

Top-level MET gene copy number gain defines a subtype of poorly differentiated pulmonary adenocarcinomas with poor prognosis

Published:2020-06 Issue:3 Volume:9 Page:603-616
ISSN:2218-6751
Container-title:Translational Lung Cancer Research
language:
Short-container-title:Transl Lung Cancer Res

Author:

Overbeck Tobias Raphael,Cron Dana Alina,Schmitz Katja,Rittmeyer Achim,Körber Wolfgang,Hugo Sara,Schnalke Juliane,Lukat Laura,Hugo Tabea,Hinterthaner Marc,Reuter-Jessen Kirsten,Rosenthal Tessa,Moecks Joachim,Bleckmann Annalen,Schildhaus Hans-Ulrich

Publisher

AME Publishing Company

Subject

Oncology

Link

http://tlcr.amegroups.com/article/download/39423/pdf

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic profile characterization of histological micropapillary and solid components in lung adenocarcinoma: a systematic review;Journal of Laboratory and Precision Medicine;2024-07

2. Tepotinib in patients with non-small cell lung cancer with high-level MET amplification detected by liquid biopsy: VISION Cohort B;Cell Reports Medicine;2023-11

3. MET Exon 14 Skipping in NSCLC: A Systematic Literature Review of Epidemiology, Clinical Characteristics, and Outcomes;Clinical Lung Cancer;2023-09

4. Real-World Data on Combined EGFR-TKI and Crizotinib Treatment for Acquired and De Novo MET Amplification in Patients with Metastatic EGFR-Mutated NSCLC;International Journal of Molecular Sciences;2023-08-23

5. NTRK Gene Fusions in Non-Small-Cell Lung Cancer: Real-World Screening Data of 1068 Unselected Patients;Cancers;2023-05-29